RARE DISEASERESEARCH ATLAS

ORPHA:673538

Littoral cell hemangioma of the spleen

medium confidenceDisorder

Also known as: LCA · Littoral cell angioma · Littoral cell haemangioma of the spleen

Publications

323

72.1th percentile

Trials

0

Interventional, condition-specific

Researchers

1,035

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    323 matched papers (137 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

323

323 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

323 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

137 in the last 10 years · medium confidence · 72.1th percentile (publications denominator)

Phrase hits: 323 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,035

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Wang X4 papers · 2026

    Yun-Qiang Cai, Xing Wang, Xun Ran, Xu-Bao Liu, Bing Peng, Department of Hepatopancreatobiliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

    Papers in Europe PMC
  2. 02
    Wang J3 papers · 2024

    From the Department of Radiology, the First Affiliated Hospital, College of Medicine, Jiaxing University.

    Papers in Europe PMC
  3. 03
    Wang L3 papers · 2024

    From the Department of Radiology, the First Affiliated Hospital, College of Medicine, Jiaxing University.

    Papers in Europe PMC
  4. 04
    Zhang Y3 papers · 2022

    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Papers in Europe PMC
  5. 05
    Zhou X3 papers · 2023

    Department of Pathology, Jinling Hospital of Southern Medical University 305 Zhongshan East Road, Nanjing 210002, Jiangsu, China.

    Papers in Europe PMC
  6. 06
    Al-Hawary MM2 papers · 2014
    Papers in Europe PMC
  7. 07
    Arber DA2 papers · 2021

    Department of Pathology, University of Chicago, Chicago, IL, USA. Electronic address: darber1@bsd.uchicago.edu.

    Papers in Europe PMC
  8. 08
    Auerbach A2 papers · 2022

    From the Department of Pathology, Walter Reed National Military Medical Center, Bethesda Maryland (Dr Borch); the Department of Hematopathology, University of Virginia, Charlottesville (Dr Aguilera); the Department of Hematopathology, Joint Pathology Center, Silver Spring, Maryland (Drs Brissette and Auerbach); and the Department of Hematopathology, NeoGenomics, Aliso Viejo, California (Dr O'Malley).

    Papers in Europe PMC
  9. 09
    Cai G2 papers · 2011
    Papers in Europe PMC
  10. 10
    Cai W2 papers · 2026

    Department of Hepatobiliary Surgery, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

medium confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Littoral cell hemangioma of the spleen" OR "Littoral cell hemangioma of spleen" OR "Littoral cell angioma" OR "Littoral cell haemangioma of the spleen" OR "Littoral cell haemangioma of spleen"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Littoral cell hemangioma of the spleen" OR "Littoral cell hemangioma of spleen" OR "Littoral cell angioma" OR "Littoral cell haemangioma of the spleen" OR "Littoral cell haemangioma of spleen"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: LCA

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T20:18:53.140Z